Details of the Drug Formulations

General Information of Drug (ID: DMG281S)

• Drug Name: Carboplatin Drug Info
• Synonyms: Azanide; Carbopaltin; Carboplatine; Carboplatino; Carboplatinum; Cbdca; Ercar; Paraplatin; Carboplatine [French]; Carboplatino [Spanish]; Carboplatinum [Latin]; C 2538; JM 8; Carboplatin (USAN); IUPAC: Azane; JM-8; Paraplatin (TN); Paraplatin, Carboplatin; Paraplatin-AQ; Cis-Diammine(cyclobutanedicarboxylato)platinumII; Platinum(+2) Cation; Carboplatin (JAN/USP/INN); Carboplatin [USAN:INN:BAN:JAN]; Cyclobutane-1,1-dicarboxylate; Cyclobutane-1,1-dicarboxylic acid; Diammine-1,1-cyclobutane dicarboxylate platinum II; Cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II); Cis-Diammine(1,1-cyclobutanedicarboxylato) platinum; Cis-Diammine(1,1-cyclobutanedicarboxylato)platinum; Cis-Diammine[1,1-cyclobutane-dicarboxylato] platinum; Diammine(1,1-cyclobutanedicarboxylato)platinum (II); Platinum, {diammine[1,1-cyclobut; Cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II); Cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II); Cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II); Platinum(II), (1, 1-cyclobutanedicar; Diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum; Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum; Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2); (SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum; 1,1-Cyclobutanedicarboxylate diammine platinum (II); 1,1-Cyclobutanedicarboxylate diammine platinum(II)

Indication

Disease Entry	ICD 11	Status	REF
Adenocarcinoma	2D40	Approved	[1]
Carcinoma	2A00-2F9Z	Approved	[1]
Cholangiocarcinoma	2C12.10	Approved	[1]
Cutaneous melanoma	2C30	Approved	[1]
Epithelial ovarian cancer	2B5D	Approved	[1]
Fallopian tube neoplasm		Approved	[1]
Gastroesophageal junction adenocarcinoma	2B71	Approved	[1]
Lung adenocarcinoma		Approved	[1]
Lung cancer	2C25.0	Approved	[1]
Non-small-cell lung cancer	2C25.Y	Approved	[1]
Ovarian cancer	2C73	Approved	[2]
Ovarian disorder		Approved	[1]
Ovarian neoplasm		Approved	[1]
Ovarian serous cystadenocarcinoma		Approved	[1]
Small-cell lung cancer	2C25.Y	Approved	[1]
Lung large cell carcinoma		Investigative	[1]
Neuroblastoma	2D11.2	Investigative	[1]

• Therapeutic Class: Anticancer Agents
• Cross-matching ID:
  PubChem CID: 426756
  ChEBI ID: CHEBI:31355
  CAS Number: 41575-94-4
  TTD ID: D0X7HM
  VARIDT ID: DR00469
  INTEDE ID: DR0272
  ACDINA ID: D00913

Full List of Drug Formulations Containing This Drug

Carboplatin 50mg/5ml injectable

Company	Formulation ID	FDA Description
Auromedics Pharma	F23666	Mannitol; Water
Accord Healthcare ; Ingenus Pharmaceuticals	F24255	Water

References

• [1] Carboplatin FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7624).